StockData
CapsoVision, Inc logo

CapsoVision, Inc (CV) stock

CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.65+0.18 (+2.78%)

Close on Nov 17, 2026Market cap $332.81MP/E –Yield –

CapsoVision operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

CapsoVision's operating cash flow for the twelve months ending Jun 30, 2026 was -$27.82M. For fiscal 2025 it was -$22.86M.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.86M–
FY2024Dec 31, 2024-$20.09M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$8.40M–
Q1 FY2026Mar 31, 2026-$6.07M–
Q4 FY2025Dec 31, 2025-$7.69M–
Q3 FY2025Sep 30, 2025-$5.67M–
Q2 FY2025Jun 30, 2025-$4.53M–
Q1 FY2025Mar 31, 2025-$4.99M–
Q4 FY2024Dec 31, 2024-$5.40M–
Q3 FY2024Sep 30, 2024-$7.06M–

More CapsoVision figures

See a number that looks wrong?